1. Home
  2. ECDA vs CALC Comparison

ECDA vs CALC Comparison

Compare ECDA & CALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ECD Automotive Design Inc.

ECDA

ECD Automotive Design Inc.

HOLD

Current Price

$1.19

Market Cap

926.4K

ML Signal

HOLD

Logo CalciMedica Inc.

CALC

CalciMedica Inc.

HOLD

Current Price

$6.23

Market Cap

88.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ECDA
CALC
Founded
2013
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
926.4K
88.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ECDA
CALC
Price
$1.19
$6.23
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$16.00
AVG Volume (30 Days)
5.8M
93.6K
Earning Date
02-14-2026
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$24,501,965.00
N/A
Revenue This Year
$21.59
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.70
$1.42
52 Week High
$206.00
$7.20

Technical Indicators

Market Signals
Indicator
ECDA
CALC
Relative Strength Index (RSI) 69.61 68.87
Support Level $0.14 $5.90
Resistance Level $0.35 $6.40
Average True Range (ATR) 0.11 0.59
MACD 0.11 0.13
Stochastic Oscillator 58.13 64.63

Price Performance

Historical Comparison
ECDA
CALC

About ECDA ECD Automotive Design Inc.

ECD Automotive Design Inc is a custom-car builder in the Restomod sector with a focus on British classic motor vehicles of various models of both two-door and four-door styles. The company has established a facility geared towards producing the majority customized Land Rovers with the highest quality of parts and the highest quality labor force building each vehicle. ECD restores Land Rovers Defenders, Land Rover Series IIA, the Range Rover Classic and the Jaguar E-Type. It upgrade any engine, including Chevrolet V8's, Land Rover V8's, Cummins diesel engines and new electric drivetrains, performing all the necessary body work, drivetrain selection and installation, every stitch in the interior, paint work, up to placement of the last nut and bolt.

About CALC CalciMedica Inc.

CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.

Share on Social Networks: